Celon Pharma
is consequently strengthening its position on the cutting edge of Polish and European research in the field of biotechnology and drug development.
Successful implementation of several modern generic drugs have promoted our brand among physicians and pharmacists.
Their trust in our products facilitated investments in research on novel, original therapeutics.
Only during last 2 years we spent more than 2 millions zlotys on pre-clinical studies.
This resulted in a significant scientific progress in areas which are company’s priorities: oncology, metabolic disorders and neurodegenerative diseases.
Choosing drug targets and treatment methods, Celon Pharma bets on the latest scientific discoveries, such as RNA interference (RNAi).
RNAi silencing of gene expression has been developed as an anti-cancer treatment at Celon Pharma from the very beginning of company’s activity and has already become our mark.
Oncology
Metabolic disorders
Alzheimer’s disease
OncologyMetabolic disordersAlzheimer’s disease
Celon Pharma Ltd
ul. Ogrodowa 2A
05-092 Lomianki, Kielpin
ul. Ogrodowa 2A
05-092 Lomianki, Kielpin
Celon Pharma © 2009 All Rights Reserved.
Designed by GREGMAR
Designed by GREGMAR